{"DataElement":{"publicId":"3420746","version":"1","preferredName":"Malignant Neoplasm Burkitt Lymphoma Histology Classification Type","preferredDefinition":"the type of Burkitt lyphoma histology associated with a malignant neoplasm.","longName":"3420745v1.0:3420740v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3420745","version":"1","preferredName":"Malignant Neoplasm Burkitt Lymphoma Histology Classification","preferredDefinition":"Burkitt Lyphoma histology of a metastasized tumor composed of atypical neoplastic, often pleomorphic cells, used for classification.","longName":"2186369v1.0:3420743v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2186369","version":"1","preferredName":"Malignant Neoplasm","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-A888-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3420743","version":"1","preferredName":"Burkitt Lymphoma Histology Classification","preferredDefinition":"A highly aggressive lymphoma composed of monomorphic medium-sized B-cells with basophilic cytoplasm and numerous mitotic figures.  It is often associated with the presence of Epstein-Barr virus (EBV) and is commonly seen in AIDS patients.  Three morphologic variants are recognized: classical Burkitt's lymphoma, Burkitt's lymphoma with plasmacytoid differentiation, and atypical Burkitt's/Burkitt's-like lymphoma.  All cases express the MYC translocation [t(8;14)]. (WHO, 2001):Histology is the study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.:A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"C2912:C0344441:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Burkitt Lymphoma","conceptCode":"C2912","definition":"A highly aggressive lymphoma composed of monomorphic medium-sized B-cells with basophilic cytoplasm and numerous mitotic figures.  It is often associated with the presence of Epstein-Barr virus (EBV) and is commonly seen in AIDS patients.  Three morphologic variants are recognized: classical Burkitt lymphoma, Burkitt lymphoma with plasmacytoid differentiation, and atypical Burkitt/Burkitt-like lymphoma.  All cases express the MYC translocation [t(8;14)]. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histology","conceptCode":"C0344441","definition":"Histology is the study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BBF00FBB-95E5-62A0-E040-BB89AD437544","latestVersionIndicator":"Yes","beginDate":"2012-03-23","endDate":null,"createdBy":"STAUFFEM","dateCreated":"2012-03-23","modifiedBy":"ONEDATA","dateModified":"2012-03-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BBF00FBB-95F6-62A0-E040-BB89AD437544","latestVersionIndicator":"Yes","beginDate":"2012-03-23","endDate":null,"createdBy":"STAUFFEM","dateCreated":"2012-03-23","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3420740","version":"1","preferredName":"Burkitt Lymphoma Histology Type","preferredDefinition":"Allows for the selection of a identifiable class for a Burkitt Lymphoma histology.","longName":"3420740v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Plasmablastic lymphoma (c-MYC positive PL)","valueDescription":"Plasmablastic lymphoma (c-MYC positive PL)","ValueMeaning":{"publicId":"3420756","version":"1","preferredName":"Plasmablastic lymphoma (c-MYC positive PL)","longName":"3420756","preferredDefinition":"plasmablastic lymphoma (PL) is a very rare subtype of DLBCL characterized by the absence of CD20, the protein targeted by rituximab. c-MYC is a gene which encodes a protein that helps turn other genes on and off. Overexpression of c-MYC (known as c-MYC positivity) is associated with a very high rate of cell proliferation in certain cancers.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BBF00FBB-972A-62A0-E040-BB89AD437544","latestVersionIndicator":"Yes","beginDate":"2012-03-23","endDate":null,"createdBy":"STAUFFEM","dateCreated":"2012-03-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BBF00FBB-9742-62A0-E040-BB89AD437544","beginDate":"2012-03-23","endDate":null,"createdBy":"STAUFFEM","dateCreated":"2012-03-23","modifiedBy":"ONEDATA","dateModified":"2012-03-23","deletedIndicator":"No"},{"value":"Burkitt Lymphoma","valueDescription":"Burkitt Lymphoma","ValueMeaning":{"publicId":"2568284","version":"1","preferredName":"Burkitt Lymphoma","longName":"2568284","preferredDefinition":"A highly aggressive lymphoma composed of monomorphic medium-sized B-cells with basophilic cytoplasm and numerous mitotic figures.  It is often associated with the presence of Epstein-Barr virus (EBV) and is commonly seen in AIDS patients.  Three morphologic variants are recognized: classical Burkitt's lymphoma, Burkitt's lymphoma with plasmacytoid differentiation, and atypical Burkitt's/Burkitt's-like lymphoma.  All cases express the MYC translocation [t(8;14)]. (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Burkitt Lymphoma","conceptCode":"C2912","definition":"A highly aggressive lymphoma composed of monomorphic medium-sized B-cells with basophilic cytoplasm and numerous mitotic figures.  It is often associated with the presence of Epstein-Barr virus (EBV) and is commonly seen in AIDS patients.  Three morphologic variants are recognized: classical Burkitt lymphoma, Burkitt lymphoma with plasmacytoid differentiation, and atypical Burkitt/Burkitt-like lymphoma.  All cases express the MYC translocation [t(8;14)]. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7C9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":"04/13/2011 - tc - Updated with current NCIt name and definition.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BBF00FBB-95D6-62A0-E040-BB89AD437544","beginDate":"2012-03-23","endDate":null,"createdBy":"STAUFFEM","dateCreated":"2012-03-23","modifiedBy":"ONEDATA","dateModified":"2012-03-23","deletedIndicator":"No"},{"value":"c-MYC positive DLBCL","valueDescription":"c-MYC positive DLBCL","ValueMeaning":{"publicId":"3420755","version":"1","preferredName":"c-MYC positive DLBCL","longName":"3420755","preferredDefinition":"c-MYC is a gene which encodes a protein that helps turn other genes on and off. Overexpression of c-MYC (known as c-MYC positivity) is associated with a very high rate of cell proliferation in certain cancers. Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's Lymphoma.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BBF00FBB-9707-62A0-E040-BB89AD437544","latestVersionIndicator":"Yes","beginDate":"2012-03-23","endDate":null,"createdBy":"STAUFFEM","dateCreated":"2012-03-23","modifiedBy":"COOPERM","dateModified":"2020-03-16","changeDescription":"Removed special characters for MDR data migration. 3.16.20 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BBF00FBB-971F-62A0-E040-BB89AD437544","beginDate":"2012-03-23","endDate":null,"createdBy":"STAUFFEM","dateCreated":"2012-03-23","modifiedBy":"ONEDATA","dateModified":"2012-03-23","deletedIndicator":"No"},{"value":"B-cell lymphoma, unclassifiable, with features intermediate between Diffuse Large B Cell Lymphoma and Burkitt Lymphoma","valueDescription":"B-Lymphocyte Lymphoma","ValueMeaning":{"publicId":"3688693","version":"1","preferredName":"B-Lymphocyte Lymphoma","longName":"3688693","preferredDefinition":"Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation.: A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B-Lymphocyte","conceptCode":"C12474","definition":"Immunologically important lymphocyte that is not thymus-dependent, is either short-lived and naive or long-lived and of memory phenotype, and resembles the bursa-derived lymphocyte of birds in that it is responsible for the production of immunoglobulins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lymphoma","conceptCode":"C3208","definition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D618A0E3-2A17-B1CF-E040-BB89AD4318D8","latestVersionIndicator":"Yes","beginDate":"2013-02-19","endDate":null,"createdBy":"LEL","dateCreated":"2013-02-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D618A0E3-2A30-B1CF-E040-BB89AD4318D8","beginDate":"2013-02-19","endDate":null,"createdBy":"LEL","dateCreated":"2013-02-19","modifiedBy":"ONEDATA","dateModified":"2013-02-19","deletedIndicator":"No"},{"value":"Classical Burkitt Lymphoma","valueDescription":"Classic Burkitt Lymphoma","ValueMeaning":{"publicId":"3613369","version":"1","preferredName":"Classic Burkitt Lymphoma","longName":"3613369","preferredDefinition":"Mature B cell, lymphoblastic, starry sky effect","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Classic Burkitt Lymphoma of the Mouse Hematologic System","conceptCode":"C21917","definition":"Mature B cell, lymphoblastic, starry sky effect","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CBCE4E2C-1AC8-5B69-E040-BB89AD436425","latestVersionIndicator":"Yes","beginDate":"2012-10-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DDEB49A2-325C-31C0-E040-BB89AD430A31","beginDate":"2013-05-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-30","modifiedBy":"ONEDATA","dateModified":"2013-05-30","deletedIndicator":"No"},{"value":"Unclassifiable B-cell lymphoma","valueDescription":"Unclassifiable B-Cell Neoplasm","ValueMeaning":{"publicId":"3773512","version":"1","preferredName":"Unclassifiable B-Cell Neoplasm","longName":"3773512","preferredDefinition":"Not arranged or included in any specific grouping.: A type of cancer that forms in B cells (a type of immune system cell). B-cell lymphomas usually occur in adults and may be either indolent (slow-growing) or aggressive (fast-growing). There are many different types of B-cell lymphomas, and prognosis and treatment depend on the type and stage of cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unclassified","conceptCode":"C64486","definition":"Not arranged or included in any specific grouping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"B-Cell Neoplasm","conceptCode":"C27907","definition":"A lymphoproliferative disorder composed of neoplastic B-cells. It includes B-cell non-Hodgkin lymphomas, B-cell leukemias, plasma cell neoplasms, and B-cell proliferations of uncertain malignant potential.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDEB49A2-3278-31C0-E040-BB89AD430A31","latestVersionIndicator":"Yes","beginDate":"2013-05-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DDEB49A2-3291-31C0-E040-BB89AD430A31","beginDate":"2013-05-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-30","modifiedBy":"ONEDATA","dateModified":"2013-05-30","deletedIndicator":"No"},{"value":"Diffuse large B-cell lymphoma (DLBCL), specify subtype","valueDescription":"Diffuse Large B-Cell Lymphoma","ValueMeaning":{"publicId":"3431650","version":"1","preferredName":"Diffuse Large B-Cell Lymphoma","longName":"3431650v1.00","preferredDefinition":"A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, and anaplastic lymphoma.  Subtypes/entities include T-cell/histiocyte rich large B-cell lymphoma, primary diffuse large B-cell lymphoma of the central nervous system, plasmablastic lymphoma, primary cutaneous diffuse large B-cell lymphoma, leg type, and ALK-positive large B-cell lymphoma._Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffuse Large B-Cell Lymphoma","conceptCode":"C8851","definition":"A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, and anaplastic lymphoma.  Subtypes/entities include T-cell/histiocyte rich large B-cell lymphoma, primary diffuse large B-cell lymphoma of the central nervous system, plasmablastic lymphoma, primary cutaneous diffuse large B-cell lymphoma, leg type, and ALK-positive large B-cell lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCE38D3C-F243-5CA3-E040-BB89AD4307F8","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"LEUNGE","dateCreated":"2012-04-04","modifiedBy":"SOKKERL","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DDEB49A2-32A5-31C0-E040-BB89AD430A31","beginDate":"2013-05-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-30","modifiedBy":"ONEDATA","dateModified":"2013-05-30","deletedIndicator":"No"},{"value":"Atypical Burkitt Lymphoma","valueDescription":"Atypical Burkitt/Burkitt-Like Lymphoma","ValueMeaning":{"publicId":"3322767","version":"1","preferredName":"Atypical Burkitt/Burkitt-Like Lymphoma","longName":"3322767","preferredDefinition":"A morphologic variant of Burkitt lymphoma characterized by marked nuclear pleomorphism, abundant apoptotic debris, and the presence of tangible body macrophages.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypical Burkitt/Burkitt-Like Lymphoma","conceptCode":"C6917","definition":"A morphologic variant of Burkitt lymphoma characterized by marked nuclear pleomorphism, abundant apoptotic debris, and the presence of tangible body macrophages.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3714D57-A8EF-7A8F-E040-BB89AD43536C","latestVersionIndicator":"Yes","beginDate":"2011-12-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DDEB49A2-32BA-31C0-E040-BB89AD430A31","beginDate":"2013-05-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-30","modifiedBy":"ONEDATA","dateModified":"2013-05-30","deletedIndicator":"No"},{"value":"Other, specify","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DDEB49A2-32CC-31C0-E040-BB89AD430A31","beginDate":"2013-05-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-30","modifiedBy":"ONEDATA","dateModified":"2013-05-30","deletedIndicator":"No"},{"value":"Unknown (Technical issues)","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DDEB49A2-32E0-31C0-E040-BB89AD430A31","beginDate":"2013-05-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-30","modifiedBy":"ONEDATA","dateModified":"2013-05-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3420739","version":"1","preferredName":"Burkitt Lymphoma Histology Type","preferredDefinition":"A highly aggressive lymphoma composed of monomorphic medium-sized B-cells with basophilic cytoplasm and numerous mitotic figures.  It is often associated with the presence of Epstein-Barr virus (EBV) and is commonly seen in AIDS patients.  Three morphologic variants are recognized: classical Burkitt's lymphoma, Burkitt's lymphoma with plasmacytoid differentiation, and atypical Burkitt's/Burkitt's-like lymphoma.  All cases express the MYC translocation [t(8;14)]. (WHO, 2001):Histology is the study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.:Something distinguishable as an identifiable class based on common qualities.","longName":"C2912:C0344441:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Burkitt Lymphoma","conceptCode":"C2912","definition":"A highly aggressive lymphoma composed of monomorphic medium-sized B-cells with basophilic cytoplasm and numerous mitotic figures.  It is often associated with the presence of Epstein-Barr virus (EBV) and is commonly seen in AIDS patients.  Three morphologic variants are recognized: classical Burkitt lymphoma, Burkitt lymphoma with plasmacytoid differentiation, and atypical Burkitt/Burkitt-like lymphoma.  All cases express the MYC translocation [t(8;14)]. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histology","conceptCode":"C0344441","definition":"Histology is the study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BBF00FBB-956B-62A0-E040-BB89AD437544","latestVersionIndicator":"Yes","beginDate":"2012-03-23","endDate":null,"createdBy":"STAUFFEM","dateCreated":"2012-03-23","modifiedBy":"ONEDATA","dateModified":"2012-03-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BBF00FBB-957C-62A0-E040-BB89AD437544","latestVersionIndicator":"Yes","beginDate":"2012-03-23","endDate":null,"createdBy":"STAUFFEM","dateCreated":"2012-03-23","modifiedBy":"REEVESD","dateModified":"2013-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5655939","version":"1","longName":"BLGSP (Burkitt Lymphoma Genome Sequencing Project)","context":"OCG","ClassificationSchemeItems":[{"publicId":"5655940","version":"1","longName":"BLGSP","context":"OCG"}]}],"AlternateNames":[{"name":"OCG","type":"USED_BY","context":"OCG"}],"ReferenceDocuments":[{"name":"Histology","type":"Preferred Question Text","description":"Histology","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BBF00FBB-9607-62A0-E040-BB89AD437544","latestVersionIndicator":"Yes","beginDate":"2012-03-23","endDate":null,"createdBy":"STAUFFEM","dateCreated":"2012-03-23","modifiedBy":"TSESU","dateModified":"2017-02-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}